Erkka Syvälahti

7.1k total citations · 1 hit paper
134 papers, 5.4k citations indexed

About

Erkka Syvälahti is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Erkka Syvälahti has authored 134 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Cellular and Molecular Neuroscience, 51 papers in Psychiatry and Mental health and 32 papers in Molecular Biology. Recurrent topics in Erkka Syvälahti's work include Neurotransmitter Receptor Influence on Behavior (52 papers), Schizophrenia research and treatment (37 papers) and Receptor Mechanisms and Signaling (29 papers). Erkka Syvälahti is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (52 papers), Schizophrenia research and treatment (37 papers) and Receptor Mechanisms and Signaling (29 papers). Erkka Syvälahti collaborates with scholars based in Finland, United States and Sweden. Erkka Syvälahti's co-authors include Jarmo Hietala, Kjell Någren, Tiina Pohjalainen, Mikko Kuoppamäki, Juha O. Rinne, Pertti Lehikoinen, Aki Laakso, Raimo K. R. Salokangas, Harry Vilkman and Merja Haaparanta‐Solin and has published in prestigious journals such as The Lancet, American Journal of Psychiatry and Annals of Surgery.

In The Last Decade

Erkka Syvälahti

131 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers

1998 570 citations Tiina Pohjalainen, Kjell Någren et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erkka Syvälahti Finland	39	2.5k	1.8k	1.2k	1.1k	782	134	5.4k
David Pickar United States	44	2.1k 0.8×	2.5k 1.4×	1.3k 1.1×	859 0.8×	852 1.1×	135	6.5k
Markku Linnoila United States	42	2.2k 0.9×	1.2k 0.7×	593 0.5×	850 0.8×	693 0.9×	115	5.5k
H. Beckmann Germany	44	2.6k 1.0×	2.6k 1.4×	1.5k 1.3×	1.6k 1.4×	861 1.1×	254	7.9k
D. Pickar United States	33	1.6k 0.7×	1.9k 1.1×	915 0.8×	686 0.6×	411 0.5×	89	4.5k
Everett H. Ellinwood United States	33	2.7k 1.1×	807 0.4×	1.0k 0.9×	1.1k 1.0×	662 0.8×	116	5.1k
Naomi Pappas United States	35	3.8k 1.5×	1.5k 0.8×	2.3k 1.9×	1.3k 1.2×	798 1.0×	50	6.7k
Toshiya Inada Japan	37	2.0k 0.8×	1.5k 0.8×	808 0.7×	1.8k 1.6×	774 1.0×	273	5.6k
I. Nicol Ferrier United Kingdom	41	1.3k 0.5×	2.5k 1.4×	1.0k 0.9×	931 0.8×	1.1k 1.4×	112	6.3k
Malcolm B. Bowers United States	36	1.6k 0.6×	1.9k 1.0×	621 0.5×	558 0.5×	712 0.9×	136	4.2k
J.A. Lieberman United States	29	1.4k 0.6×	3.2k 1.8×	952 0.8×	882 0.8×	470 0.6×	50	5.2k

Countries citing papers authored by Erkka Syvälahti

Since Specialization

Citations

This map shows the geographic impact of Erkka Syvälahti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkka Syvälahti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkka Syvälahti more than expected).

Fields of papers citing papers by Erkka Syvälahti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erkka Syvälahti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkka Syvälahti. The network helps show where Erkka Syvälahti may publish in the future.

Co-authorship network of co-authors of Erkka Syvälahti

This figure shows the co-authorship network connecting the top 25 collaborators of Erkka Syvälahti. A scholar is included among the top collaborators of Erkka Syvälahti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erkka Syvälahti. Erkka Syvälahti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vilkman, Harry, Jaana Kajander, Sargo Aalto, et al.. (2009). The effects of lorazepam on extrastriatal dopamine D2/3-receptors—A double-blind randomized placebo-controlled PET study. Psychiatry Research Neuroimaging. 174(2). 130–137. 9 indexed citations

Bola, John R., Klaus Lehtinen, Jukka Aaltonen, et al.. (2006). Predicting Medication-Free Treatment Response in Acute Psychosis. The Journal of Nervous and Mental Disease. 194(10). 732–739. 12 indexed citations

Aalto, Sargo, Jouni Ihalainen, Jussi Hirvonen, et al.. (2005). Cortical glutamate–dopamine interaction and ketamine-induced psychotic symptoms in man. Psychopharmacology. 182(3). 375–383. 74 indexed citations

Hallikainen, Tero, Jarmo Hietala, Jussi Kauhanen, et al.. (2003). Ethanol consumption and DRD2 gene TaqI a polymorphism among socially drinking males. American Journal of Medical Genetics Part A. 119A(2). 152–155. 21 indexed citations

Salokangas, Raimo K. R., Tyrone D. Cannon, Tuula Ilonen, et al.. (2002). Structural magnetic resonance imaging in patients with first-episode schizophrenia, psychotic and severe non-psychotic depression and healthy controls. The British Journal of Psychiatry. 181(S43). s58–s65. 54 indexed citations

Aalto, Sargo, Jussi Hirvonen, Jaana Kajander, et al.. (2002). Ketamine does not decrease striatal dopamine D 2 receptor binding in man. Psychopharmacology. 164(4). 401–406. 52 indexed citations

Laakso, Aki, Jörgen Bergman, Merja Haaparanta‐Solin, et al.. (2001). Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophrenia Research. 52(1-2). 115–120. 85 indexed citations

Pälvimäki, Esa-Pekka, Mikko Kuoppamäki, Erkka Syvälahti, & Jarmo Hietala. (1999). Differential effects of fluoxetine and citalopram treatments on serotonin 5-HT2C receptor occupancy in rat brain. The International Journal of Neuropsychopharmacology. 2(2). 95–99. 25 indexed citations

Taiminen, Tero, Erkka Syvälahti, Simo Saarijãrvi, et al.. (1997). Is Positive Placebo Response in Chronic Schizophrenia Investigator-Dependent?. The Journal of Nervous and Mental Disease. 185(10). 644–644. 1 indexed citations

10.

Hietala, Jarmo & Erkka Syvälahti. (1996). Dopamine in Schizophrenia. Annals of Medicine. 28(6). 557–561. 74 indexed citations

11.

Kuoppamäki, Mikko, Esa-Pekka Pälvimäki, Jarmo Hietala, & Erkka Syvälahti. (1995). Differential Regulation of Rat 5-HT2A and 5-HT2C Receptors after Chronic Treatment with Clozapine, Chlorpromazine and Three Putative Atypical Antipsychotic Drugs. Neuropsychopharmacology. 13(2). 139–150. 16 indexed citations

12.

Hietala, Jarmo, Erkka Syvälahti, Mikko Kuoppamäki, et al.. (1995). Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. The Lancet. 346(8983). 1130–1131. 254 indexed citations

13.

Syvälahti, Erkka, Aki Laakso, Esa-Pekka Pälvimäki, Mikko Kuoppamäki, & Jarmo Hietala. (1995). P-2-50 Up-regulation of 5-HT2C receptors by citalopram and fluoxetine in rat brain. European Neuropsychopharmacology. 5(3). 291–291. 1 indexed citations

14.

Syvälahti, Erkka, Tiina Pohjalainen, Esa R. Korpi, et al.. (1994). Dopamine D₂ Receptor Gene Expression in Rat Lines Selected for Differences in Voluntary Alcohol Consumption. Alcoholism Clinical and Experimental Research. 18(4). 1029–1031. 25 indexed citations

15.

Syvälahti, Erkka, et al.. (1992). Citalopram, a specific inhibitor of serotonin reuptake in treatment of psychotic and borderline patients. Nordic Journal of Psychiatry. 46(3). 181–187. 9 indexed citations

16.

Syvälahti, Erkka, et al.. (1985). Depression and the dexamethasone suppression test (DST) in patients with non-specific somatic complaints. Atypical depression and DST.. PubMed. 17(4). 148–51.

17.

Äärimaa, M., et al.. (1978). Insulin, growth hormone and catecholamines as regulators of energy metabolism in the course of surgery.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 144(7-8). 411–22. 18 indexed citations

18.

Pentikäinen, P J, Pertti J. Neuvonen, S Tarpila, & Erkka Syvälahti. (1978). Effect of cirrhosis of the liver on the pharmacokinetics of chlormethiazole.. BMJ. 2(6141). 861–863. 27 indexed citations

19.

Hyyppä, Markku T., et al.. (1976). L-Tryptophan administration in man: effects on gonadotrophin, growth hormone and cortisol secretion and on sexual motivation.. PubMed. 3. 102–352. 3 indexed citations

20.

Lammintausta, Risto, Erkka Syvälahti, & A. Pekkarinen. (1976). Change in hormones reflecting sympathetic activity in the Finnish sauna.. PubMed. 8(4). 266–71. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact